Trump Strikes Drug Pricing Deals With 9 Pharma Giants: What It Means for Your Portfolio
President Trump announces Most Favored Nation drug pricing deals with 9 major pharma companies. In exchange for price cuts, drugmakers get tariff exemptions.
TRENDING TOPICS
3286 articles found for "investing"
President Trump announces Most Favored Nation drug pricing deals with 9 major pharma companies. In exchange for price cuts, drugmakers get tariff exemptions.
Bank of Japan raises rates to 0.75%, the highest since 1995, but the yen slides past 157 per dollar. 10-year JGB yield breaks 2% for first time since 1999.
TikTok signs deal to spin off U.S. operations to Oracle-led consortium. The $14B agreement creates a new joint venture with 50% American ownership.
FedEx reports Q2 earnings beat with 19% EPS growth as freight spinoff preparations advance. Stock rises on raised guidance despite MD-11 fleet headwinds.
Nike shares plunge after Q2 FY26 earnings despite beating estimates. China revenue drops 17% while tariffs threaten margins. Is the turnaround story dead?
Micron reports record $13.64B revenue with 57% growth as AI memory demand explodes. HBM supply sold out through 2026 as stock surges 14%.
Nike reports fiscal Q2 earnings after the bell Thursday. With a new COO and mounting competitive pressure, can the Swoosh finally show signs of a turnaround?
U.S. stocks surged Thursday as cooler-than-expected CPI and Micron's blowout earnings reversed a four-day losing streak. Nasdaq jumped 1.5%.
The Bank of Japan is expected to raise rates to 0.75% on Friday—the highest since 1995. Here's why the decision could ripple through global markets.
Activist investor Elliott has built a $1 billion-plus stake in Lululemon and is proposing former Ralph Lauren executive Jane Nielsen as CEO candidate.
Trump Media announced a $6 billion merger with TAE Technologies, creating one of the first publicly traded nuclear fusion companies. DJT stock surged 35%.
Micron stock jumped 12% after posting record earnings and guiding for $18.7 billion in Q2 revenue. The AI memory boom shows no signs of slowing.